Literature DB >> 12354750

Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).

Peggy A Campo1, Sonali Das, Chin-Hui Hsiang, Tim Bui, Charles E Samuel, Daniel S Straus.   

Abstract

The D-group cyclins play a key role in the progression of cells through the G(1) phase of the cell cycle. Treatment of MCF-7 breast cancer cells with the cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) results in rapid down-regulation of cyclin D1 protein expression and growth arrest in the G(0)/G(1) phase of the cell cycle. 15d-PGJ(2) also down-regulates the expression of cyclin D1 mRNA; however, this effect is delayed relative to the effect on cyclin D1 protein levels, suggesting that the regulation of cyclin D1 occurs at least partly at the level of translation or protein turnover. Treatment of MCF-7 cells with 15d-PGJ(2) leads to a rapid increase in the phosphorylation of protein synthesis initiation factor eukaryotic initiation factor 2alpha (eIF-2alpha) and a shift of cyclin D1 mRNA from the polysome-associated to free mRNA fraction, indicating that 15d-PGJ(2) inhibits the initiation of cyclin D1 mRNA translation. The selective rapid decrease in cyclin D1 protein accumulation is facilitated by its rapid turnover (t(1/2) = 34 min) after inhibition of cyclin D1 protein synthesis. The half-life of cyclin D1 protein is not significantly altered in cells treated with 15d-PGJ(2). Treatment of cells with 15d-PGJ(2) results in strong induction of heat shock protein 70 (HSP70) gene expression, suggesting that 15d-PGJ(2) might activate protein kinase R (PKR), an eIF-2alpha kinase shown previously to be responsive to agents that induce stress. 15d-PGJ(2) strongly stimulates eIF-2alpha phosphorylation and down-regulates cyclin D1 expression in a cell line derived from wild-type mouse embryo fibroblasts but has an attenuated effect in PKR-null cells, providing evidence that PKR is involved in mediating the effect of 15d-PGJ(2) on eIF-2alpha phosphorylation and cyclin D1 expression. In summary, treatment of MCF-7 cells with 15d-PGJ(2) results in increased phosphorylation of eIF-2alpha and inhibition of cyclin D1 mRNA translation initiation. At later time points, repression of cyclin D1 mRNA expression may also contribute to the decrease in cyclin D1 protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354750

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  11 in total

1.  High-throughput polyribosome fractionation.

Authors:  Yipeng Wang; Steven Ringquist; Ann H Cho; Gaelle Rondeau; John Welsh
Journal:  Nucleic Acids Res       Date:  2004-06-01       Impact factor: 16.971

2.  Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle.

Authors:  Rocio Tapia; Miriam Huerta; Socorro Islas; Antonia Avila-Flores; Esther Lopez-Bayghen; Jörg Weiske; Otmar Huber; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

3.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

4.  Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.

Authors:  Woo Jae Kim; Joon Hyun Kim; Sung Key Jang
Journal:  EMBO J       Date:  2007-11-22       Impact factor: 11.598

5.  Transcriptional and post-transcriptional profile of human chromosome 21.

Authors:  Sergey I Nikolaev; Samuel Deutsch; Raphael Genolet; Christelle Borel; Leila Parand; Catherine Ucla; Frederic Schütz; Genevieve Duriaux Sail; Yann Dupré; Pascale Jaquier-Gubler; Tanguy Araud; Beatrice Conne; Patrick Descombes; Jean-Dominique Vassalli; Joseph Curran; Stylianos E Antonarakis
Journal:  Genome Res       Date:  2009-07-06       Impact factor: 9.043

Review 6.  15d-PGJ2 is a new hope for controlling tumor growth.

Authors:  Qingli Bie; Haixin Dong; Chengqiang Jin; Hao Zhang; Bin Zhang
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

7.  A rapid microwell fluorescence immunoassay for cellular protein detection.

Authors:  Carole Lavigne; de Arméle Guignée; Alain R Thierry
Journal:  Biol Proced Online       Date:  2008-09-22       Impact factor: 3.244

8.  Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling.

Authors:  Simon R Stockwell; Georgina Platt; S Elaine Barrie; Georgia Zoumpoulidou; Robert H Te Poele; G Wynne Aherne; Stuart C Wilson; Peter Sheldrake; Edward McDonald; Mathilde Venet; Christelle Soudy; Frédéric Elustondo; Laurent Rigoreau; Julian Blagg; Paul Workman; Michelle D Garrett; Sibylle Mittnacht
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  15-Deoxy-Δ12,14-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response.

Authors:  Devin Tauber; Roy Parker
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

10.  TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.

Authors:  Daniel S Straus
Journal:  Mol Cancer       Date:  2013-07-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.